Press Releases Austrian MedTech Biome Diagnostics goes NASDAQBiome Diagnostics receives multiple awards for excellence, and advertising space at NASDAQ Tower in Times…Catia PacificoJune 27, 2023
Press Releases BiomeDx and SanusX announce strategic partnershipSanusX acquires a stake of around 20% in Austrian MedTech company Biome Diagnostics GmbH Vienna,…Catia PacificoJune 26, 2023
Press Releases BiomeDx Wins Startup Audience AwardAustrian MedTech Biome Diagnostics convinces investor jury and audience Vienna, November 7, 2022 - Biome…Nikolaus GascheNovember 8, 2022
Press Releases Intestinal microbiome as cancer hope: new predictive test makes life easier for patientsVIENNA, July 2022: Vienna-based Biome Diagnostics launches the first and only gut microbiome-based predictive test…Nikolaus GascheJuly 18, 2022
Press Releases Biome Diagnostics identifies tumor-agnostic biomarker for cancer immunotherapy in a new meta-analysis of microbiome studiesBiome Diagnostics (BiomeDx) presents new meta-analysis which reinforces the significance of the intestinal microbiome as…Nikolaus GascheNovember 2, 2021
Press Releases Biome Diagnostics has received six-digit funding from the Austrian Research Promotion Agency (FFG)VIENNA, April 2021: Biome Diagnostics GmbH is a global leader in microbiome diagnostics and specializes…Barbara SladekMay 21, 2021
Press Releases Bioinformatics scale-up Biome Diagnostics launches Austria-wide, multi-centre cancer study “BiomeOne”In cooperation with several Austrian hospitals, Biome Diagnostics GmbH, known for its product "myBioma", is…Nikolaus GascheMarch 22, 2021
Press Releases myBioma becomes Biome DiagnosticsAs the worldwide leading microbiome diagnostic start-up pushes forward in the medical field, myBioma GmbH…Nikolaus GascheFebruary 20, 2021
Press Releases Successful completion of the Data Science Bootcamp of the Austrian Research Promotion Agency (FFG)VIENNA, January 2021: From April to December 2020, myBioma‘s bioinformatician Christian Jansen had the chance…Nikolaus GascheJanuary 25, 2021